Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 8Breast 3Gastrointestinal 2Thoracic 1Sarcoma 1Gynecologic 1CNS 1

Conditions

Rectal Neoplasms 45Colorectal Neoplasms 45Esophageal Neoplasms 28Esophageal Squamous Cell Carcinoma 24Stomach Neoplasms 22Pancreatic Neoplasms 19Colonic Neoplasms 18Adenocarcinoma Of Esophagus 15Carcinoma, Hepatocellular 14Neoplasm Metastasis 7Liver Neoplasms 6Cholangiocarcinoma 5Recurrence 4Locally Advanced Rectal Cancer 4Turcot syndrome 3Peritoneal Neoplasms 2Neoplasms 2Gastrointestinal Stromal Tumors 2Breast Neoplasms 2Bites and Stings 2Adenocarcinoma 2Surgery 1Successful Conversion Rate of Operation 1Radiation Injuries 1QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy 1Peritoneal Metastases From Gastric Cancer 1Peritoneal Metastases From Colorectal Cancer 1Pathologic Complete Response 1Pancreatic Ductal Adenocarcinoma (PDAC) 1Pancreatic Ductal Adenocarcinoma 1

Interventions

Gemcitabine 69Fluorouracil 44pembrolizumab 43Oxaliplatin 42Capecitabine 40Bevacizumab 37Leucovorin 36Irinotecan 31Cisplatin 27Nivolumab 24Paclitaxel 21Cetuximab 21Panitumumab 20130-nm albumin-bound paclitaxel 20Sorafenib 18Albumin-Bound Paclitaxel 18Drug Therapy 15Docetaxel 15Cyclophosphamide 15Radiotherapy 14Blood Specimen Collection 14IFL protocol 12atezolizumab 11Exercise 11Taxes 10budigalimab 9Erlotinib Hydrochloride 9trametinib 8Folfox protocol 8Carboplatin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Neoadjuvant Therapy × Gastrointestinal × Clear all
NCT05496491 2024-10-08

Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial

Larissa University Hospital

Phase NA Recruiting
84 enrolled
Gastrointestinal

Neoplasms, Rectal Neoplasms

NCT01458717 2018-05-02

Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer

Seoul National University Hospital

Phase 2/3 Completed
58 enrolled
Gastrointestinal

Neoplasms, Pancreatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡